Join Free For Buyer|Sign In

Professional Online Trade Platform for API, Preparation and Pharmaceutical Machinery and Equipment_EN-CPhI.cn

You are here:  Home >>  News >>  Research & Development >>  Alembic Pharma’s approves NCDs up to Rs 300 crore

Alembic Pharma’s approves NCDs up to Rs 300 crore

June 14, 2019 By expressbpd

The company, which did not specify the reasons for raising funds, said it will issue NCDs in one or more tranches

Drug firm Alembic Pharmaceuticals said its board has approved raising of up to Rs 300 crore through issuance of non-convertible debentures (NCDs) on a private placement basis.

The company, which did not specify the reasons for raising funds, said it will issue NCDs in one or more tranches.

“The board of directors of Alembic has approved the issue of unsecured listed rated redeemable non-convertible debentures (NCDs) of up to Rs 300 crore on a private placement basis,” the company said in a regulatory filing.

Shares of Alembic Pharmaceuticals were trading 0.03 percent higher at Rs 502.20 apiece on the BSE.

By PTI 

-----------------------------------------------------------------------
Editor's Note:

If you have any suggestion to the content, 

please email: Julia.Zhang@ubmsinoexpo.com

Readers'Comments
Add a comment
Click here to Login or to Register for free. You will be taken back to your selected item after Login/Registration.
More>> MarketNews
More>> Editors’Picks
More>> TopStories
More>> HotTags
Follow Us
CPhI Online Trade Platform: Worldwide|English|中国站
Customer Service:  86-400 610 1188 (9: 00-18: 00, Mon-Fri)
About Us| Contact Us| Terms of Services| Privacy Policy| Intellectual Property Statement| Links | Site Map
Copyright 2006-20 Shanghai UBM Sinoexpo International Exhibition Co Ltd (All Rights Reserved). ICP 05034851-53
网页对话
live chat